Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN Y7017 (memantine) + donepezil in moderate to severe Alzheimer's disease
jRCT1080221701Phase 4
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Alzheimer's disease (AD) comparing Memantine + donepezil with Placebo + donepezil (2 arms).
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT1080221701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221701.